The Lifespan.io crowdfunding site has a mitochondrial allotopic
expression project currently funded and in the final days that you might
find interesting. It seems like something that - aside from the cost of
reagents - is within the capabilities of many of the more capable folk
in the DIYbio community. The details are certainly worth a read:
https://www.lifespan.io/campaigns/sens-mitochondrial-repair-project/
The reagent cost issue is kind of an interesting one for DIYbio. The
community has made some inroads into address the basic equipment cost,
might it also at some point tackle reagents? Or is this something where
the path of least resistance is just to wait, expecting the cost
implosion for biotechnology to reach these areas as well sooner or later?
Another quite fascinating project is the attempt to kick DRACO
anti-virus research across the finish line; it is a way to treat near
all viruses by killing the cells they replicate in. The inefficiencies
in progress are occasionally puzzling; DRACO has solid studies backing
it, and a near complete lack of interest from the development community.
It is also something where some parts of the work taken in isolation are
projects that could in theory be replicated in the DIYbio community, out
of interest or curiosity.
https://www.indiegogo.com/projects/help-end-viral-diseases-with-dracos#/
Lastly I'm raising funds for SENS research again this year: a group of
us created a $125,000 matching fund and we will match all donations made
to the SENS Research Foundation before the end of the year:
https://www.fightaging.org/fund-research/
SENS research has had a banner year this year. Oisin Biotechnology has
been seed funded to develop a means of senescent cell clearance, another
group demonstrated proof of principle senescent cell clearance and
corresponding health improvements in mice, Human Rejuvenation
Technologies was founded to develop lysosomal aggregate clearing enzymes
as a therapy, a method of synthesizing glucosepane was published in
Science, Gensight has raised a boatload of money for their allotopic
expression work, and in general things are starting to happen as a
consequence of past years of philanthropy.
Reason